Ke Yao

2.5k total citations
61 papers, 2.0k citations indexed

About

Ke Yao is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ke Yao has authored 61 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Ke Yao's work include Melanoma and MAPK Pathways (13 papers), Cell death mechanisms and regulation (7 papers) and Cancer-related Molecular Pathways (7 papers). Ke Yao is often cited by papers focused on Melanoma and MAPK Pathways (13 papers), Cell death mechanisms and regulation (7 papers) and Cancer-related Molecular Pathways (7 papers). Ke Yao collaborates with scholars based in United States, China and South Korea. Ke Yao's co-authors include Zigang Dong, Ann M. Bode, Yong‐Yeon Cho, Feng Zhu, Duo Zheng, Hanyong Chen, Tatyana A. Zykova, Cong Peng, Margarita Malakhova and Chul-Ho Jeong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Ke Yao

59 papers receiving 2.0k citations

Peers

Ke Yao

ONCOL

PFM

Tatyana A. Zykova United States

Dong Joon Kim China

Monica Savio Italy

Nanyue Chen United States

Jian Huang China

Wei-Ya Ma United States

Shih‐Hsin Tu Taiwan

Limin Hu China

Moammir Hasan Aziz United States

Tatyana A. Zykova United States

Ke Yao

1.2k ×0.8

322 ×0.8

ONCOL

174 ×0.6

157 ×0.9

206 ×1.2

PFM

Citations per year, relative to Ke Yao Ke Yao (= 1×) peers Tatyana A. Zykova

Countries citing papers authored by Ke Yao

Since Specialization

Citations

This map shows the geographic impact of Ke Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Yao more than expected).

Fields of papers citing papers by Ke Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Yao. The network helps show where Ke Yao may publish in the future.

Co-authorship network of co-authors of Ke Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Yao. A scholar is included among the top collaborators of Ke Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Yao. Ke Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Jinchao, et al.. (2025). Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma. Discover Oncology. 16(1). 1734–1734.

Zhang, Weizhe, Zubair Hussain, Qiong Wu, et al.. (2024). Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC. Translational Oncology. 50. 102136–102136. 1 indexed citations

Wang, Qiushi, Tianshun Zhang, Do Young Lim, et al.. (2020). ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis. Cancer Research. 80(19). 4158–4171. 5 indexed citations

Lee, Kun Y., Ke Yao, Seung Ho Shin, et al.. (2020). GSK3β-Mediated Expression of CUG-Translated WT1 Is Critical for Tumor Progression. Cancer Research. 81(4). 945–955. 7 indexed citations

Jin, Guoguo, Kangdong Liu, Ke Yao, et al.. (2020). Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer. Oncogene. 39(43). 6733–6746. 16 indexed citations

Zhang, Tianshun, Qiushi Wang, Ge Gao, et al.. (2018). The Ashitaba ( Angelica keiskei ) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Cancer Prevention Research. 11(10). 607–620. 11 indexed citations

Zykova, Tatyana A., Feng Zhu, Lei Wang, et al.. (2018). Targeting PRPK Function Blocks Colon Cancer Metastasis. Molecular Cancer Therapeutics. 17(5). 1101–1113. 15 indexed citations

Gao, Ge, Tianshun Zhang, Kanamata Reddy, et al.. (2017). ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK. Molecular Cancer Therapeutics. 16(9). 1843–1854. 27 indexed citations

Yang, Ge, Yang Fu, Margarita Malakhova, et al.. (2014). Caffeic Acid Directly Targets ERK1/2 to Attenuate Solar UV-Induced Skin Carcinogenesis. Cancer Prevention Research. 7(10). 1056–1066. 47 indexed citations

10.

Yao, Ke, Hanyong Chen, Kangdong Liu, et al.. (2014). Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer. Cancer Prevention Research. 7(9). 958–967. 58 indexed citations

11.

Yao, Ke, Hanyong Chen, Mee‐Hyun Lee, et al.. (2013). Licochalcone A, a Natural Inhibitor of c-Jun N -Terminal Kinase 1. Cancer Prevention Research. 7(1). 139–149. 36 indexed citations

12.

Liu, Kangdong, Donghoon Yu, Yong‐Yeon Cho, et al.. (2013). Sunlight UV-Induced Skin Cancer Relies upon Activation of the p38α Signaling Pathway. Cancer Research. 73(7). 2181–2188. 53 indexed citations

13.

Zhu, Feng, Tatyana A. Zykova, Cong Peng, et al.. (2011). Phosphorylation of H2AX at Ser139 and a New Phosphorylation Site Ser16 by RSK2 Decreases H2AX Ubiquitination and Inhibits Cell Transformation. Cancer Research. 71(2). 393–403. 33 indexed citations

14.

Xu, Yan‐Ming, Feng Zhu, Yong‐Yeon Cho, et al.. (2010). Extracellular Signal-Regulated Kinase 8–Mediated c-Jun Phosphorylation Increases Tumorigenesis of Human Colon Cancer. Cancer Research. 70(8). 3218–3227. 45 indexed citations

15.

Liu, Kangdong, Yong‐Yeon Cho, Ke Yao, et al.. (2010). Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation. Journal of Biological Chemistry. 286(3). 2057–2066. 52 indexed citations

16.

Cho, Yong‐Yeon, Ke Yao, Angelo Pugliese, et al.. (2009). A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity. Cancer Research. 69(10). 4398–4406. 58 indexed citations

17.

Bode, Ann M., Yong‐Yeon Cho, Duo Zheng, et al.. (2009). Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis. Cancer Research. 69(3). 905–913. 74 indexed citations

18.

Cho, Yong‐Yeon, Faqing Tang, Ke Yao, et al.. (2008). Cyclin-Dependent Kinase-3–Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation. Cancer Research. 69(1). 272–281. 54 indexed citations

19.

Yao, Ke, Yong‐Yeon Cho, H. Robert Bergen, et al.. (2007). Nuclear Factor of Activated T3 Is a Negative Regulator of Ras-JNK1/2-AP-1–Induced Cell Transformation. Cancer Research. 67(18). 8725–8735. 15 indexed citations

20.

Cho, Yong‐Yeon, Ke Yao, Hong-Gyum Kim, et al.. (2007). Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter–Induced Cell Transformation. Cancer Research. 67(17). 8104–8112. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact